Smith & Nephew Overview
- Year Founded
-
1855
- Status
-
Public
- Employees
-
18,000
- Stock Symbol
-
SN.
- Investments
-
54
- Share Price
-
$12.50
- (As of Friday Closing)
Smith & Nephew General Information
Description
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Contact Information
Website
www.smith-nephew.comCorporate Office
- Building 5, Croxley Park
- Hatters Lane
- Watford WD18 8YE
- England, United Kingdom
Corporate Office
- Building 5, Croxley Park
- Hatters Lane
- Watford WD18 8YE
- England, United Kingdom
Smith & Nephew Timeline
Smith & Nephew Stock Performance
As of 06-Dec-2024, Smith & Nephew’s stock price is $12.50. Its current market cap is $10.9B with 872M shares.
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$12.50 | $12.43 | $11.77 - $16.00 | $10.9B | 872M | 2.86M | $0.35 |
Smith & Nephew Financials Summary
As of 30-Jun-2024, Smith & Nephew has a trailing 12-month revenue of $5.64B.
In Thousands, USD |
TTM 30-Jun-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
---|---|---|---|---|
EV | 13,593,695 | 14,842,083 | 14,000,912 | 17,537,035 |
Revenue | 5,642,000 | 5,549,000 | 5,215,000 | 5,212,000 |
EBITDA | 983,000 | 922,000 | 860,000 | 1,236,000 |
Net Income | 305,000 | 263,000 | 223,000 | 524,000 |
Total Assets | 10,542,000 | 9,987,000 | 9,966,000 | 10,920,000 |
Total Debt | 3,655,000 | 3,084,000 | 2,872,000 | 3,339,000 |
Smith & Nephew Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Smith & Nephew Comparisons
Industry
Financing
Details
Smith & Nephew Competitors (23)
One of Smith & Nephew’s 23 competitors is Globus Medical, a Formerly VC-backed company based in Audubon, PA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Globus Medical | Formerly VC-backed | Audubon, PA | ||||
Medtronic | Corporation | Minneapolis, MN | ||||
Orthofix International | Formerly PE-Backed | Lewisville, TX | ||||
Baxter India | Corporation | Gurgaon, India | ||||
Aspen Surgical | Private Equity-Backed | Caledonia, MI |
Smith & Nephew Patents
Smith & Nephew Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
GB-2624657-A | Method of limb scanning | Pending | 24-Nov-2022 | ||
GB-2626230-A | Method | Pending | 23-Nov-2022 | ||
EP-4452353-A1 | Systems and methods for controlling pressure delivery by negative pressure wound therapy devices | Pending | 21-Dec-2021 | ||
EP-4448035-A1 | Smart battery pack with power saving modes for negative pressure wound therapy devices | Pending | 13-Dec-2021 | ||
EP-4437748-A1 | Device communication management in user activity monitoring systems | Pending | 24-Nov-2021 | H04W12/65 |
Smith & Nephew Signals
Smith & Nephew Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Smith & Nephew Investments & Acquisitions (54)
Smith & Nephew’s most recent deal was a Later Stage VC with Miach Orthopaedics for . The deal was made on 02-Apr-2024.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Miach Orthopaedics | 02-Apr-2024 | Later Stage VC | Surgical Devices | ||
CartiHeal | 09-Jan-2024 | Merger/Acquisition | Therapeutic Devices | ||
Additive Instruments | 09-Mar-2023 | Merger/Acquisition | Surgical Devices | ||
Engage Surgical | 18-Jan-2022 | Merger/Acquisition | Therapeutic Devices | ||
Integra LifeSciences (Extremity Orthopedic Business) | 04-Jan-2021 | Merger/Acquisition | Therapeutic Devices |
Smith & Nephew Subsidiaries (6)
Company Name | Industry | Location | Founded |
---|---|---|---|
CartiHeal | Therapeutic Devices | Kfar Saba, Israel | 2009 |
Rotation Medical | Pharmaceuticals | Plymouth, MN | |
Atracsys | Diagnostic Equipment | Puidoux, Switzerland | |
EuroCiencia Colombia | Medical Supplies | Bogota, Colombia | |
Oratec Interventions | Surgical Devices | Manassas, VA |
Smith & Nephew ESG
Risk Overview
Risk Rating
Updated October, 02, 2024
21.03 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,100
Rank
Percentile
Healthcare
Industry
of 588
Rank
Percentile
Medical Devices
Subindustry
of 200
Rank
Percentile
Smith & Nephew Exits (4)
Smith & Nephew’s most recent exit was on 01-Dec-2016 from OrthoSpace. The exit was categorized as with 4 buyers.
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
OrthoSpace | 01-Dec-2016 | Completed |
|
||
OrthoSpace | 19-May-2015 | Completed |
|
||
BSN medical | 01-Apr-2001 | Completed |
|
||
Jobskin Australia | 01-Jan-1991 | Merger/Acquisition | Completed |
Smith & Nephew FAQs
-
When was Smith & Nephew founded?
Smith & Nephew was founded in 1855.
-
Where is Smith & Nephew headquartered?
Smith & Nephew is headquartered in Watford, United Kingdom.
-
What is the size of Smith & Nephew?
Smith & Nephew has 18,000 total employees.
-
What industry is Smith & Nephew in?
Smith & Nephew’s primary industry is Medical Supplies.
-
Is Smith & Nephew a private or public company?
Smith & Nephew is a Public company.
-
What is Smith & Nephew’s stock symbol?
The ticker symbol for Smith & Nephew is SN..
-
What is the current stock price of Smith & Nephew?
As of 06-Dec-2024 the stock price of Smith & Nephew is $12.50.
-
What is the current market cap of Smith & Nephew?
The current market capitalization of Smith & Nephew is $10.9B.
-
What is Smith & Nephew’s current revenue?
The trailing twelve month revenue for Smith & Nephew is $5.64B.
-
Who are Smith & Nephew’s competitors?
Globus Medical, Medtronic, Orthofix International, Baxter India, and Aspen Surgical are some of the 23 competitors of Smith & Nephew.
-
What is Smith & Nephew’s annual earnings per share (EPS)?
Smith & Nephew’s EPS for 12 months was $0.35.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »